Maia Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Sell
2,598
-314
-11% -$67.6K 0.09% 185
2026
Q1
$585K Sell
2,912
-116
-4% -$24K 0.1% 196
2025
Q4
$621K Sell
3,028
-187
-6% -$37.4K 0.11% 193
2025
Q3
$632K Sell
3,215
-654
-17% -$111K 0.11% 184
2025
Q2
$624K Sell
3,869
-215
-5% -$34.2K 0.12% 172
2025
Q1
$636K Sell
4,084
-572
-12% -$99.3K 0.14% 153
2024
Q4
$835K Sell
4,656
-69
-1% -$11.8K 0.18% 115
2024
Q3
$795K Buy
4,725
+60
+1% +$9.93K 0.2% 108
2024
Q2
$746K Buy
+4,665
New +$700K 0.22% 94
2023
Q4
$596K Buy
+3,770
New +$542K 0.24% 82

Other funds holding FBT

Maia Wealth's FBT Position: Q2 2026 in Review

Maia Wealth reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 11% in Q2 2026, selling an estimated $67.6K and leaving 2,598 shares worth $644K. The position accounts for 0.09% of the portfolio, ranked #185.

Maia Wealth first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $835K in Q4 2024. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Maia Wealth held 2,598 shares of First Trust NYSE Arca Biotechnology Index Fund worth $644K as of Q2 2026.
  • Maia Wealth sold 314 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $67.6K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Maia Wealth's portfolio in Q2 2026, its #185 holding.
  • Maia Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
  • Maia Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $835K in Q4 2024.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Maia Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.